Eton Pharmaceuticals (ETON) Other financing activities (2019 - 2025)

Eton Pharmaceuticals has disclosed Other financing activities across 7 years of filings, most recently posting $204000.0 for Q4 2025.

• In Q4 2025, Other financing activities fell 97.01% year-over-year to $204000.0; the TTM figure through Dec 2025 stood at $598000.0 (down 91.46% YoY), while the FY2025 annual figure was $598000.0, down 91.46% from the prior year.
• Other financing activities came in at $204000.0 for Q4 2025 at Eton Pharmaceuticals, down from $394000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $6.8 million in Q4 2024 to a low of -$59000.0 in Q4 2023.
• Average Other financing activities over 5 years is $533687.5, with a median of $110000.0 recorded in 2021.
• Year-over-year, Other financing activities tumbled 410.53% in 2023 and surged 11666.1% in 2024.
• Over 5 years, Other financing activities stood at $68000.0 in 2021, then sank by 72.06% to $19000.0 in 2022, then plunged by 410.53% to -$59000.0 in 2023, then surged by 11666.1% to $6.8 million in 2024, then tumbled by 97.01% to $204000.0 in 2025.
• Per Business Quant data, the three most recent Other financing activities figures were $204000.0 in Q4 2025, $394000.0 in Q1 2025, and $6.8 million in Q4 2024.